Atlanticus' Q3 Revenue Rises-March 2024-www.financetom.com

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Atlanticus' Q3 Revenue Rises

Nov 10, 2025 6:19 AM

08:44 AM EST, 11/10/2025 (MT Newswires) -- Atlanticus ( ATLC ) reported Q3 adjusted net income Monday of $1.48 per diluted share.

Three analysts polled by FactSet expected $1.98.

Revenue for the quarter ended Sept. 30 was $494.7 million, up from $351.2 million a year earlier.

Analysts surveyed by FactSet expected $495.5 million.

Previous page： Italy may strengthen digital services tax in 2025 budget, sources say Next page： The Marcus Files Universal Shelf Registration Statement for up to $150 Million of Securities

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Italy may strengthen digital services tax in 2025 budget, sources say

Oct 7, 2024

* Washington threatened tariffs against EU digital taxes * U.S. commerce secretary to meet Italy PM this week * Italy to raise corporate taxes to finance 2025 budget By Giuseppe Fonte ROME, Oct 7 (Reuters) - Italy is considering ways to increase revenues from its digital services tax as part of its 2025 budget, two officials said, although the government...

The Marcus Files Universal Shelf Registration Statement for up to $150 Million of Securities

Oct 7, 2024

07:05 AM EDT, 10/07/2024 (MT Newswires) -- The Marcus (MCS) said Friday that it has filed a new universal shelf registration statement with the Securities and Exchange Commission to potentially offer securities of up to $150 million to the public. This replaces the company's previous universal shelf registration statement which was set to expire later this month, the company said....

Blue Owl to buy IPI Partners for about $1 bln

Oct 7, 2024

Oct 7 (Reuters) - Asset manager Blue Owl said on Monday it has agreed to buy digital infrastructure fund manager IPI Partners for about $1 billion. ...

Scholar Rock's genetic disease drug meets main goal in late-stage trial

Oct 7, 2024

Oct 7 (Reuters) - Scholar Rock ( SRRK ) said on Monday its drug met the main goal in a late-stage trial testing it on patients with a type of genetic neuromuscular disease. ...